Further to an earlier posting about Merck and Elsevier combining on a fake journal, Elsevier now acknowledges that there were six "sponsored article publications."
Elsevier Published Six Fake Journals
May 8, 2009
Share this post
2 Comments

Law Bytes
Episode 257: Lisa Given on What Canada Can Learn From Australia’s Youth Social Media Ban
byMichael Geist

February 9, 2026
Michael Geist
Episode 256: Jennifer Quaid on Taking On Big Tech With the Competition Act's Private Right of Access
February 2, 2026
Michael Geist
The Law Bytes Podcast, Episode 255: Grappling with Grok – Heidi Tworek on the Limits of Canadian Law
January 26, 2026
Michael Geist
December 22, 2025
Michael Geist
December 8, 2025
Michael Geist
Search Results placeholder
Recent Posts
The Law Bytes Podcast, Episode 257: Lisa Given on What Canada Can Learn From Australia’s Youth Social Media Ban
Court Ordered Social Media Site Blocking Coming to Canada?: Trojan Horse Online Harms Bill Clears Senate Committee Review
An Illusion of Consensus: What the Government Isn’t Saying About the Results of its AI Consultation
The Law Bytes Podcast, Episode 256: Jennifer Quaid on Taking On Big Tech With the Competition Act’s Private Right of Access
Government Says There Are No Plans for National Digital ID To Access Services

Use bugmenot to read the article
If you do not want to register just to read an article, use bugmenot.com to enter the-scientist site.
Sick and tired of walled gardens like Elsevier? Support Science Commons
http://sciencecommons.org/about/
Quote:
There are petabytes of research data being produced in laboratories around the world, but the best web search tools available can’t help us make sense of it. Why? Because more stands between basic research and meaningful discovery than the problem of search.
Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are balkanized — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close. It’s not uncommon for research sponsors to invest hundreds of millions of dollars in critically important efforts like drug discovery, only to see them fail.
The consequences in many cases are no less than tragic. The time it takes to go from identifying a gene to developing a drug currently stands at 17 years — forever, for people suffering from disease.